Preferred Homecare (Park Infusioncare LP), Dallas, TX

Is Preferred Homecare (Park Infusioncare LP) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility, with FDA’s note “Out of business”.

Does Preferred Homecare (Park Infusioncare LP) hold a Texas pharmacy license?

No license with this exact name and city was found in the Texas State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The Colorado State Board of Pharmacy also lists nonresident license OSP 5438 for Park Infusion Care, Dallas, TX, status Expired, as of Nov 15, 2026.

Has Preferred Homecare (Park Infusioncare LP) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Jun 12, 2019) for Preferred Homecare (Park Infusioncare LP). Texas board disciplinary orders: not checked, because the board’s file flags orders only on a license, and no license matched this name and city.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Park Infusioncare LP; Preferred Homecare
Location
Dallas, TX
Type as FDA labels it
503A
FDA’s note
Out of business
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Jun 12, 2019
FDA Data Dashboard inspections
1 inspection: 1 OAI; 1 published Form 483
Form 483 text on this page
1 Form 483, 5 observations
State board records
No exact match

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Park Infusioncare LP (dba Preferred Homecare), a 503A facility, with 1 dated action.

Document
Jun 12, 2019Warning letter close-outWarning Letter Close Out Issued 06/12/2019Not linked by FDA

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Park Infusioncare LP, Dallas, TX (FEI number 3013330273), matched to this page by exact name, city and state. It lists 1 inspection: 1 OAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Jul 11, 2017Official Action Indicated (OAI)Drug Quality Assurance (Drugs)30133302731018556

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 5 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Jun 27, 2017 to Jul 11, 2017: 5 observations

Firm on the cover
Park Infusioncare LP dba Preferred Homecare, 13621 Inwood Road, Suite 420, Dallas, TX 75244
FEI number
3013330273
Establishment type on the cover
Sterile Drug Producer
FDA district office on the cover
4040 North Central Expressway, Suite 300 Dallas, TX 75204
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

This 483 is a scanned image. The text below is the PDF’s own text layer, which can misread characters; the PDF is the record.

Observation 1

Vermin was observed in your production area.

Specificall y

( of(4) I

I. On 06/28/17, one dead insect was observed on top of ISO 5 Hood REDACTED (b) (4) (Serial # REDACTED (b)(4) inside the Cleanroom. Additionally, one dead insect was observed on the bottom shelf of the r efrigerator used for storing your finished produced sterile products and one dead insect was observed on the bott om shelf of the refrigerator used for storing drug ingredients to be produced.

2. Your ISO 5 Hoods are not constructed for appropriate cleaning and maintenance. Reddish-brown residue was observed under the contact surface grating of ISO 5 Hood REDACTED (b)(4) Serial # REDACTED (b ) (4 ) a nd ISO 5 REDACTED (b) (4) and ISO 5 REDACTED (b) (4) where the operator performs sterile production.

3. Ceiling tile of the Anteroom appeared to display reddish-brown discoloration.

4. The Anteroom door was observed to have an approximately one and a half (1 1/2) inch gap from the bottom of the door to the floor which exposed the Anteroom to the unclassified area. ...

Read the full 483 (PDF on fda.gov)

Observation 2

Personnel were observed touching equipment or other surfaces located outside of the ISO 5 area with gloved hands and then proceeding with aseptic processing without changing or sanitizing gloves.

Specifically,

A. On 06/27/17, an operator was observed opening the door of the Cleanroom to grab supplies in the Anteroom and then re-entered the Cleanroom to proceed with the preparation of 3 in I TPN 120gm Protein 1800ml, for RX

REDACTED (b) (6), (b) (7)(C) without changing or sanitizing gloves.

B. On 06/28/ 17, an operator was observed donning sterile gloves improperly by touching the outside of the sterile gloves with her bare hands.

Observation 3

Media fills were not performed that closely simulate aseptic production operations incorporating, as appropriate, worst-case activities and conditions that provide a challenge to aseptic operations.

Specifically, your media fill consists of REDACTED (b) (4) and the c ontents ge t REDACTED (b)(4) However, this process does not simulate the most challenging aseptic manipulations performed at your firm such as the processing of your TPN

sterile products. According to your Pharmacy Manager, the aseptic process for TPN products requires the foll owing steps which include but are not limited to: setti ng up the REDACTED (b) (4) the specified amount of i ngredient s (i. e., REDACTED (b) (4 ) into the REDACTED (b ) ( 4) o pe ra tor REDACTED (b) (4) , then the operator REDACTED (b)(4)

Observation 4

Disinfecting agents and cleaning pads or wipes used in the ISO 5 area (aseptic processing areas) are not sterile.

Specifically,

A. Disinfectants, REDACTED (b)(4) and REDACTED (b)(4) Wipes, used to clean surfaces and equipment in the ISO 5 Hoods, ISO 7 Cleanroom, and ISO 7 Chemoroom are non-sterile.

B. The low-lint wipes used to clean surfaces and equipment in the ISO 5 Hoods are non-sterile.

Observation 5

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

Specifically,

A. Your environmental monitoring samples (viable air, surface monitoring plate, and finger touch plate) are not incubated at an adequate temperature and duration to recover the appropriate microorganisms. Per manufacturer's instruction for use of contact sampling plates, REDACTED ( b)

(4) Ho we ve r, you r environmental air and surface cont act plate s s ampled from IS O 5 Ho ods were documented to be incubated only at REDACTED (b)(4) F (~REDACTED (b)(4)C) for REDACTED (b) (4 ) da ys. Ad di ti on al ly , fi ng er t ou ch

pl ate s wer e also do cum ented to be incubated only a t REDACTED ( b)(4) C fo r REDACTED (b )( 4) d ays.

B. According to your ISO rooms and hoods certification records, REDACTED (b) (4)/m3 was recovered from viable air sample collected from your ISO 5 REDACTED (b) (4) J (Serial # REDACTED (b) (4) on 04/24/17 and on 10/17/16. Your firm has not performed investigation into the source of the contamination.

State board of pharmacy records

No license with this exact name and city was found in the Texas State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. Board file.

What this covers: The file marks whether a license has prior disciplinary orders (column DISP ACTN, Y or N) but does not list them; the orders are on the board’s license lookup, which this index does not copy. The board says orders entered more than 10 years ago are not online.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).

LicenseType as the board gives itName on the board recordLocationStatus
OSP 5438OSPPark Infusion CareDallas, TXExpired

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.